Markets:

Overview

News

Currencies

International

Treasuries

ACADIA Pharmaceuticals Inc. - Common Stock (NQ:ACAD)

23.99 -0.34 (-1.40%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about ACADIA Pharmaceuticals Inc. - Common Stock

ACADIA PHARMACEUTICALS INC (NASDAQ:ACAD) Combines Strong Fundamentals with Bullish Technicals for Growth Potential ↗

August 16, 2025

ACADIA Pharmaceuticals (ACAD) shows strong growth fundamentals with rising revenue, EPS, and solid margins, plus a bullish technical breakout, making it a promising stock pick.

Via Chartmill

Acadia (ACAD) Q2 Revenue Rises 9% ↗

August 06, 2025

Via The Motley Fool

Topics Intellectual Property

ACADIA PHARMACEUTICALS INC (NASDAQ:ACAD) Q2 2025 Earnings: Revenue Growth Meets Expectations, EPS Beats Estimates ↗

August 06, 2025

Acadia Pharmaceuticals reports Q2 2025 earnings with $264.6M revenue (+9% YoY), EPS beats at $0.16. NUPLAZID & DAYBUE sales grow, reaffirms full-year guidance. Stock up 12.5% in past month.

Via Chartmill

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

July 30, 2025

Via Benzinga

The Analyst Verdict: ACADIA Pharmaceuticals In The Eyes Of 11 Experts ↗

June 05, 2025

Via Benzinga

Earnings Scheduled For May 7, 2025 ↗

May 07, 2025

Via Benzinga

Demystifying ACADIA Pharmaceuticals: Insights From 5 Analyst Reviews ↗

February 27, 2025

Via Benzinga

Earnings Scheduled For February 26, 2025 ↗

February 26, 2025

Via Benzinga

ACADIA PHARMACEUTICALS INC (NASDAQ:ACAD) – A High-Growth Biotech Stock with Fair Valuation ↗

July 25, 2025

ACADIA Pharmaceuticals (ACAD) offers strong growth, solid profitability, and fair valuation, making it a top pick for investors seeking affordable growth in biotech.

Via Chartmill

What Analysts Are Saying About ACADIA Pharmaceuticals Stock ↗

July 24, 2025

Via Benzinga

ACADIA PHARMACEUTICALS INC (NASDAQ:ACAD) – A Strong Growth Stock with Technical Breakout Potential ↗

July 22, 2025

ACADIA PHARMACEUTICALS (NASDAQ:ACAD) shows strong growth fundamentals and a bullish technical setup, making it a noteworthy stock for growth investors.

Via Chartmill

Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity ↗

July 10, 2025

Acadia Pharmaceuticals is working on its next-generation Nuplazid and, for CEO Catherine Owen Adams, the journey is personal.

Via Investor's Business Daily

Topics Intellectual Property

ACADIA PHARMACEUTICALS INC (NASDAQ:ACAD) - A Promising Growth Stock at a Reasonable Valuation ↗

July 04, 2025

ACADIA PHARMACEUTICALS (NASDAQ:ACAD) offers strong growth potential with reasonable valuation, solid financial health, and improving profitability, making it a compelling candidate for growth...

Via Chartmill

ACADIA PHARMACEUTICALS INC (NASDAQ:ACAD) – A Strong Growth Stock with Technical Breakout Potential ↗

June 24, 2025

ACADIA PHARMACEUTICALS (NASDAQ:ACAD) shows strong growth fundamentals and a bullish technical setup, making it a stock to watch for potential breakout opportunities.

Via Chartmill

13 Analysts Assess ACADIA Pharmaceuticals: What You Need To Know ↗

June 23, 2025

Via Benzinga

ACADIA PHARMACEUTICALS INC (NASDAQ:ACAD) - A Promising Affordable Growth Stock ↗

June 12, 2025

ACADIA PHARMACEUTICALS (NASDAQ:ACAD) offers strong growth potential with reasonable valuation, solid financial health, and improving profitability, making it an interesting candidate for growth...

Via Chartmill

JPMorgan Lifts Acadia Price Target After Nuplazid Patent Victory ↗

June 06, 2025

Acadia wins Nuplazid patent case, extending protection to 2038, as JP Morgan boosts price target ahead of key appeal on the ‘740 COM patent.

Via Benzinga

Topics Intellectual Property

ACADIA PHARMACEUTICALS INC (NASDAQ:ACAD) - A Promising Growth Stock at a Reasonable Valuation ↗

May 22, 2025

ACADIA PHARMACEUTICALS (NASDAQ:ACAD) offers strong growth potential with reasonable valuation, solid financial health, and improving profitability, making it an interesting stock for growth investors.

Via Chartmill

These Analysts Boost Their Forecasts On Acadia Pharmaceuticals ↗

May 19, 2025

Via Benzinga

Forecasting The Future: 8 Analyst Projections For ACADIA Pharmaceuticals ↗

May 19, 2025

Via Benzinga

Netflix To $1,220? Here Are 10 Top Analyst Forecasts For Monday ↗

May 19, 2025

Via Benzinga

Acadia Pharmaceuticals (ACAD) Stock Explodes 26% After Patent Court Victory ↗

May 16, 2025

ACADIA Pharmaceuticals stock jumped 26.4% Friday afternoon. Shares gained following a favorable court ruling.

Via Benzinga

Topics Intellectual Property

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 16, 2025

Via Benzinga

Top stock movements in today's session. ↗

May 16, 2025

Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Evolv Technologies, Quantum Computing, ACADIA Pharmaceuticals And Other Big Stocks Moving Higher On Friday ↗

May 16, 2025

Via Benzinga

The market is filled with gapping stocks in Friday's session. ↗

May 16, 2025

Let's delve into the US markets on Friday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

Via Chartmill

NASDAQ:ACAD, an undervalued stock with good fundamentals. ↗

February 21, 2025

ACADIA PHARMACEUTICALS INC is a hidden gem, featuring undervaluation and robust fundamentals. NASDAQ:ACAD showcases decent financial health and profitability, coupled with an attractive price.

Via Chartmill

While growth is established for NASDAQ:ACAD, the stock's valuation remains reasonable. ↗

February 17, 2025

ACADIA PHARMACEUTICALS INC was identified as an affordable growth stock. NASDAQ:ACAD is showing great growth, but also scores well on profitability. At the same time it seems to be priced reasonably.

Via Chartmill

10 Health Care Stocks With Whale Alerts In Today's Session ↗

February 12, 2025

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

ACADIA Pharmaceuticals Inc. - Common Stock (NQ:ACAD)

Headline News about ACADIA Pharmaceuticals Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today